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ABSTRACT
Homing endonucleases (HEs) promote the evolu-
tionary persistence of selfish DNA elements by
catalyzing element lateral transfer into new host or-
ganisms. The high site specificity of this lateral
transfer reaction, termed homing, reflects both the
length (14–40bp) and the limited tolerance of target
or homing sites for base pair changes. In order to
better understand molecular determinants of
homing, we systematically determined the binding
and cleavage properties of all single base pair
variant target sites of the canonical LAGLIDADG
homing endonucleases I-CreI and I-MsoI. These
Chlorophyta algal HEs have very similar three-
dimensional folds and recognize nearly identical
22bp target sites, but use substantially different
sets of DNA-protein contacts to mediate
site-specific recognition and cleavage. The site spe-
cificity differences between I-CreI and I-MsoI
suggest different evolutionary strategies for HE per-
sistence. These differences also provide practical
guidance in target site finding, and in the generation
of HE variants with high site specificity and cleavage
activity, to enable genome engineering applications.
INTRODUCTION
The lateral transfer of mobile introns or inteins into new
host organisms is termed ‘homing’ (1–4). The homing
reaction has three speciﬁc components: the laterally
transferred genetic element, typically a self-splicing
intron or intein; a homing endonuclease (HE) protein,
often encoded within the mobile intron or intein; and a
target or ‘homing’ site that can be cleaved by a cognate
HE. Target site cleavage initiates recombination-mediated
repair using the homologous intron or intein-containing
donor allele as a repair template. Successful repair results
in transfer of the mobile intron or intein into the
cleaved host target site to create a new intron-containing
(or ‘intron+’) allele. Intron/intein insertion disrupts
the target site, and thus prevents additional rounds
of cleavage that could result in intron loss. Homing
is thus an efﬁcient, unidirectional lateral transfer mechan-
ism that ensures the potential for additional rounds of
intron or intein lateral transfer into HE cleavage-sensitive
hosts (4).
Several hundred HEs encoded by mobile introns or
inteins have been identiﬁed across all domains of life.
These HEs have been categorized into ﬁve families on
the basis of shared sequence motifs: the LAGLIDADG,
HNH, His-Cys box, GIY-YIG and PD-(D/E)XK HE
families (5,6). The LAGLIDADG homing endonuclease
(LHE) family, with several hundred members, is the
largest and best-studied of these families (7,8). LHE
proteins share an abbaba core fold in which the conserved
‘LAGLIDADG’ protein motif forms a dimerization or
intra- molecular folding interface, and contributes catalyt-
ic acidic aspartic or glutamic acid residues to the nuclease
active sites. DNA target site recognition is mediated by
contacts made by LHE amino acid side chains to DNA
bases or to the phosphodiester backbone. Most of these
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sheets ﬂanking the LAGLIDADG interface.
The high site speciﬁcity of LHE cleavage reﬂects the
large number of phased, direct and water-mediated
contacts made by LHEs to target site DNA (5). Despite
their high site speciﬁcity, many LHEs appear to tolerate
some target site base pair changes without a loss of site
binding or cleavage [see, e.g. (9,10)]. This seemingly para-
doxical combination—high site speciﬁcity with the ability
to tolerate target site base pair changes—may be evolu-
tionarily advantageous: high site speciﬁcity minimizes
toxicity to current hosts by limiting off-target cleavage,
while the ability to tolerate target site genetic variation
may maximize the potential for continued lateral spread
(11–14).
In order to better understand the molecular determin-
ants of homing and lateral transfer, we determined the
ability of two well-characterized, homologous LHE
proteins to bind and to cleave all single base pair
variants of their native DNA target sites. The proteins,
I-CreI and I-MsoI, are encoded by mobile introns in the
chloroplast DNAs of different Chlorophyta algal species.
Both homodimeric endonucleases share a common
three-dimensional fold and 22bp target sites that differ
at only 2 of 22bp positions. The I-CreI and I-MsoI
target sites are pseudo-palindromic, reﬂecting the
homodimeric architecture of both endonucleases, and
have left and right halves that share, respectively, 7 of
11 and 5 of 11 bases (Figure 1) (15,16). Our prior struc-
tural analyses demonstrated that I-CreI and I-MsoI use
Figure 1. I-CreI, I-MsoI and their monomeric variants. (A) Crystal structure of I-CreI (green) bound with target site DNA (red) (17). The I-CreI
target site is shown below the co-crystal structure, with target site nucleotide positions numbered relative to the center of symmetry. Two-fold
symmetric, palindromic target site positions are shown in shaded boxes, and the location of top and bottom strand cleavage sites by ﬁlled arrows.
mCreI, a monomeric/single chain version of I-CreI, was generated by connecting the two I-CreI domains with a 33 amino acid residue linker whose
sequence is shown below the target site in single letter amino acid code. The unique portion of the linker, located between ﬂexible GS repeats, is
underlined (19). (B) Crystal structures of I-MsoI (green) and mMsoI (cyan) bound with their DNA target site (18,19). The I-MsoI target site,
location of palindromic target site positions and the location of cleavage sites are indicated as in (A) above. The 33 residue linker sequence used to
create mMsoI is indicated below the target site in single letter amino acid code with the unique portion of the linker underlined (19). (C) DNA–
protein interfaces of I-CreI and I-MsoI bound to native DNA target sites. The DNA–protein contact maps for I-CreI (top) and I-MsoI (bottom)
were determined from their respective co-crystal structures (17,18) and redrawn in common format. Protein side chains that are conserved in
structure and DNA binding function are indicated by yellow ovals. Base pairs at the ±11 positions, shown in pink, differed from native target
site base pairs and were included in successful crystallization oligonucleotides.
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recognize their target sites (Figure 1C) (17,18). In work
reported here, we systematically determined the in vitro
binding and cleavage properties of I-CreI, I-MsoI and
the monomeric versions mCreI and mMsoI (19) on
all single base pair variant DNA target sites (Figure 1).
We also determined the in vivo cleavage speciﬁcity proﬁles
for mCreI and mMsoI in human cells using the same
target site libraries.
MATERIALS AND METHODS
Materials
The bacterial protein expression plasmids pET15b and
pET24d were obtained from Novagen (Gibbstown, NJ,
USA). The Escherichia coli protein expression host
strain C2566 was obtained from New England Biolabs
(Ipswich, MA, USA). DNA oligonucleotides (50-nmol
scale, salt-free) were synthesized by Operon (Huntsville,
AL, USA). Qiaquick PCR puriﬁcation kits and Ni-NTA
HisSorb plates were obtained from Qiagen (Valencia, CA,
USA). Other reagents, including restriction enzymes, Taq
DNA polymerase and T4 DNA ligase were obtained from
New England Biolabs (Ipswich, MA, USA) or
Sigma-Aldrich (St Louis, MO, USA).
Protein expression and puriﬁcation
Homing endonuclease proteins were expressed and
puriﬁed as previously described by nickel afﬁnity chroma-
tography (19). Proteins for in vitro binding assays were
expressed from pET15b with an N-terminal 6 His
afﬁnity puriﬁcation/binding tag. Proteins used for
in vitro cleavage assays were expressed and puriﬁed from
pET24d without afﬁnity tags.
In vitro binding speciﬁcity
The in vitro target site binding afﬁnities were determined
using a competitive binding assay as previously described
(20). In brief, proteins with N-terminal 6 His tags were
immobilized in Ni-NTA HisSorb 96-wells plates (Qiagen)
by incubating 200ml of 100nM protein in TBS/BSA buffer
(50mM Tris-HCl pH 7.5, 150mM NaCl, 0.2% BSA) with
plate wells for 2h at room temperature. Unbound protein
was removed by washing plates four times with TBS/
Tween-20 [50mM Tris-HCl (pH 7.5), 150mM NaCl,
0.05% Tween-20]. Immobilized proteins were then
incubated with a mixture of 100nM ﬂuorescently labeled
native target site DNA and 3mM (a 30-fold excess) of each
of three unlabeled competitor target site DNAs containing
alternative base pair substitutions at a given target site
base pair position in 200ml of binding buffer [50Mm
Tris, pH 7.5, 150mM NaCl, 0.02mg/ml poly(dI-dC),
10mM CaCl2]. After incubation for 4h at room tempera-
ture, plates were washed four times with TBS (50mM
Tris, pH 7.5, 150mM NaCl). Retained ﬂuorescence was
quantiﬁed on a SpectraMax M5/M5e microplate reader
(Molecular Devices; excitation, 510nm; emission, 565nm;
cutoff, 550nm). All measurements were performed in
triplicate, and relative in vitro binding afﬁnities were
calculated using the following formula:
Relative binding affinity ¼
½ðFðnÞ FðxÞÞ   FðtÞ =½ðFðnÞ FðtÞÞ   FðxÞ 
where F(x), F(t) and F(n) indicate ﬂuorescence intensities
of wells containing immobilized protein that were
incubated with unlabeled base substitution target sites
[F(x)] or with the native [F(t)] or a scrambled sequence
target site [F(n)].
In vitro cleavage speciﬁcity
I-CreI or I-MsoI target site were synthesized as
pairs of complementary DNA oligonucleotides which
were annealed and ligated into the XhoI and SacI sites
of the recombination reporter plasmid pDR-GFP-univ,
a universal target site version of pDR-GFP
(19,21) (http://depts.washington.edu/monnatws/plasmids/
pDR-GFP-univ.pdf). The I-CreI site library consisted of
61 unique target site plasmids: a native I-CreI target site
plasmid and 60 additional plasmids with single base pair
substitutions covering target site positions  10 to +10.
The corresponding I-MsoI site library consisted of 67
unique target site plasmids: a native I-MsoI target site
plasmid and 66 additional plasmids with single base sub-
stitutions covering target site positions  11 to+11. Each
target site was ampliﬁed from pDR-GFP-univ plasmid
DNA using pairs of primers that placed the target site at
the center of different-sized amplicon products.
Amplicons harboring target site A substitutions were
2200bp long, and those with C, G or T substitutions
were, respectively, 1900, 1600 or 1320bp long (Figure
3A). After puriﬁcation, equimolar amounts of the four
DNA substrate fragments were combined to generate 20
I-CreI (or 22 I-MsoI) substrate pools for competitive
in vitro cleavage assays.
HE proteins for in vitro cleavage assays were expressed
in E. coli host strain C2566 from pET24d and puriﬁed as
previously described (19). In vitro cleavage assays were
conducted in 20mM Tris pH 8.0, 10mM MgCl2 with
1:1 protein/DNA ratio under conditions where  50% of
the wild-type target site was cleaved. This corresponded to
15min at 37 C for I-CreI/mCreI, and 1h at 37 C for
I-MsoI/mMsoI. Digests were stopped by adding loading
buffer containing 0.1% SDS to samples, and the ladders
of substrate and product fragments from each digest
were separated by agarose gel electrophoresis. Fragment
band intensities were quantiﬁed after staining using
ImageQuant (Molecular Dynamics). Target site cleavage
efﬁciency was calculated from the ratio of substrate to
product bands, normalized to the cleavage efﬁciency of
the native base pair at each target site position to
generate a relative in vitro cleavage index.
In vitro competitive cleavage assay
The plasmid substrate for in vitro competitive cleavage
assays were constructed by cloning both a native and a
test target site into pCcdB (22) at two different locations:
the native target site into AﬂIII/BglII-cleaved plasmid
Nucleic Acids Research,2012, Vol.40, No. 6 2589DNA, and the test target site into NheI/SacII-cleaved
plasmid DNA. In order to perform competitive cleav-
age assays, plasmid substrates were linearized by XbaI
digestion, and 100ng of linear plasmid substrate was
incubated with LHEs in the presence of 20mM Tris pH
8.0, 100mM NaCl, 10mM MgCl2 for 1h at 37 C.
Cleavage reactions were quenched by adding 10mM
EDTA and 1% SDS followed by heating for 10min at
60 C. Plasmid substrate and cleavage products were
separated by agarose gel electrophoresis, visualized by
staining with ethidium bromide and photographed for
quantitation.
In vivo cleavage/recombination assays
The ability of mCreI and mMsoI to cleave target sites in
human cells was determined using a human cell transient
transfection assay as previously described [Figure 4A;
(19)]. In brief, 293T cells (3 10
5 cells/well in 500mlo f
growth medium) were plated in 24-well plates 1 d prior
to transfection and grown in a 37 C humidiﬁed, 5% CO2
incubator. Complete growth medium consisted of
Dulbecco-modiﬁed Eagle’s medium (Cellgro) supple-
mented with 10% fetal bovine serum (Cellgro) and 1%
penicillin/streptomycin (Gibco). Wells were 50–80% con-
ﬂuent at the time of co-transfection with a pDR-GFP-univ
target site plasmid and a coding plasmid for either mCreI
or mMsoI. Transfections contained a total of 1.5mg
plasmid DNA/well (3:1 molar ratio of expression to
target site plasmid DNA), and were performed overnight
at 3% CO2 using a modiﬁed calcium phosphate protocol
(19,23).
Transfected cells were analyzed by ﬂow cytometry 48h
after transfection to quantify the frequency of generation
of cleavage-depenent GFP+ recombinant cells. In brief,
cells were tryspinized and washed in PBS, resuspended
at  10
6cells/ml in PBS buffer and then stained with
propidium iodine (10ng/ml) prior to analysis on an
Inﬂux ﬂow cytometer (Cytopeia). Typically 50000 events
were scored for each transfected sample by gating log side
versus linear forward scatter and for PI exclusion to
quantify the fraction of GFP+ viable cells. Transfection
efﬁciency was monitored in all experiments by using a
GFP+ positive control vector pEGFP-C1 (Clontech) in
the same experiment. In vivo cleavage efﬁciencies for
single base pair variant target sites were calculated from
the percent GFP+ cells, corrected for transfection efﬁ-
ciency and normalized against the GFP+ frequency of
the native base pair at each target site position.
RESULTS
In vitro binding speciﬁcity
Target site binding afﬁnities for all four proteins
were determined using a competitive binding assay (20).
In brief, N-terminal 6 His-tagged HE proteins were
immobilized in 96-well plates, then incubated with a
ﬂuorescently labeled native target site oligonucleotide
followed by a 30-fold molar excess of unlabeled competi-
tor target site DNA. Competitor sites included the native
target site, single base pair variant target sites or an unre-
lated sequence as a control for non-speciﬁc binding.
Relative binding afﬁnities were calculated from competi-
tor concentration-speciﬁc loss of ﬂuorescence. Figure 2
displays the in vitro binding proﬁles for the native
homodimers I-CreI and I-MsoI.
The 10bp positions in the I-CreI target site (±3–5 and
±9–10) that were palindromically symmetric between the
left and right half sites displayed a strong preference to
bind native target site base pairs, and greatly reduced
afﬁnities ( 10% of native) for each of the other 3bp
(Figure 2, top panel). Base pairs at these positions make
multiple direct or water-mediated contacts (17,18). In
contrast, the central four target site positions ( 2t o+ 2 )
that make no base-speciﬁc contacts with I-CreI were able
to bind 1 or 2bp in addition to the native base pair with
afﬁnities of  50% that of the native base pair. Seven of
Figure 2. In vitro binding speciﬁcity proﬁles of I-CreI and I-MsoI. The relative binding afﬁnities of I-CreI (top) and I-MsoI (bottom) for all 4bp at
each target site position were determined using a competitive in vitro binding assay (20). Target site base pair numbering is as in Figure 1, with
positions differing between I-CreI and I-MsoI shown in boxes ( 9 and +10 positions). Bar heights indicate the binding afﬁnity of each protein for
base pair substitutions relative to binding of the native base pair whose binding has been arbitrarily set as 1.0. All results are the mean of three
replications in which the standard deviation between experiments was ±5%. Error bars have been omitted for graphical clarity.
2590 Nucleic Acids Research, 2012,Vol.40, No. 6the eight remaining I-CreI target site positions (±6–7,+8
and ±11) each bound at least one variant base pair with
afﬁnities of  50% that of the native base pair (Figure 2,
top panel). Only 7 of 66 single base pair substitutions in
the I-CreI target site displayed binding afﬁnities compar-
able to the native base pair ( 6C>T, +1G>A,
+2A >Co rT ,+ 6 A >G, +8T>A and +11G>A,
Figure 2, top panel). Of note, many base pair variants
with high binding afﬁnities increased the overall
symmetry of the I-CreI target site (see, e.g.  7A>C
and +7G>T;  6C>T and +6A>G, Figure 2, top
panel).
The in vitro binding proﬁle of I-MsoI differed substan-
tially from I-CreI and was less speciﬁc. I-MsoI had only
4bp positions (versus I-CreI’s 10), positions  9, ±5 and
 3, with a strong preference for binding only the native
base pair (Figure 2, bottom panel). I-MsoI was also more
tolerant of base pair changes in the central four target site
positions ( 2 to+2), where all three alternative base pairs
could be bound with afﬁnities ranging from 30 to 90% of
Figure 3. In vitro cleavage speciﬁcity proﬁles of I-CreI and I-MsoI. (A) Outline of the ‘bar code’ cleavage assay used to assess the comparative
cleavage efﬁciency of target sites with base pair substitutions (see Methods). Hypothetical base-speciﬁc or non-speciﬁc cleavage patterns are depicted
at right (25). (B) Agarose gels displaying in vitro cleavage speciﬁcity proﬁles for I-CreI and I-MsoI determined as described in panel (A).
(C) Quantitation of cleavage speciﬁcity data in (B), where bar heights indicate extent of cleavage of base pair substitutions relative to the native
base pair whose cleavage efﬁciency has been arbitrarily set to 1.0. All results are the mean of three replicates in which the standard deviations were
±5%. Error bars have been omitted for graphical clarity.
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pair substitutions that increased overall target site
symmetry, e.g. at positions +6 and +9, increased site
binding afﬁnity (Figure 2, bottom panel).
A conspicuous difference between I-MsoI and I-CreI
was site binding symmetry: the left I-MsoI half site ( 3
to  11) displayed higher binding speciﬁcity than did
I-CreI, whereas the right I-MsoI half site had six positions
(+6 to +11) where one or more variant base pair was
bound with  50% of the afﬁnity of the native base pair.
This difference in I-MsoI half site binding afﬁnities agrees
with our prior analysis of the I-MsoI DNA binding
thermodynamic proﬁle (24).
We used these site binding data to calculate global
binding speciﬁcities for I-CreI and I-MsoI. The binding
speciﬁcity of I-CreI was  1.8 10
 10, which was
calculated by dividing the number of variant target sites
that were bound with  50% of native site afﬁnity
(n=3072) by the number of unique target sites of
length 22bp (n=4
22=1.8 10
13). The corresponding
binding speciﬁcity of I-MsoI was approximately an
order of magnitude lower, or  1.6 10
 9. The corres-
ponding binding speciﬁcity proﬁles of mCreI and
mMsoI closely resembled their respective parental
proteins (Supplementary Figure S1), although their
calculated binding speciﬁcities were lower:  1.6 10
 9
for mCreI, and  2.0 10
 6 for mMsoI. This difference
may reﬂect the presence of the 33 residue linkers inserted
to monomerize I-CreI and I-MsoI (Figure 1) (19), and/or
the presence of two His tags on the subunits of the
homodimeric proteins as opposed to the single tag on
each corresponding monomeric protein in binding assays.
In vitro cleavage speciﬁcity
In vitro cleavage speciﬁcities were determined using a
single tube, competitive ‘bar code’ cleavage assay to sim-
ultaneously assess the cleavage sensitivity of all 4bp
possibilities at each target site position (Figure 3A) (25).
Target site libraries were constructed in pDR-GFPuniv
(http://depts.washington.edu/monnatws/plasmids/pDR-
GFP%20univ.pdf) to permit the same target site libraries
to be used for in vitro and in vivo cleavage speciﬁcity de-
terminations (Figure 4; see below). In vitro cleavage con-
ditions were determined to ensure  50% cleavage of the
native target site at a 1:1 protein:DNA ratio. This ratio
was chosen to minimize the effect of binding afﬁnity
Figure 4. The in vivo cleavage speciﬁcity proﬁles of mCreI and mMsoI. (A) Assay used to measure in vivo cleavage efﬁciency of variant target sites in
human cells, where target site cleavage leads to the generation of GFP+ recombinant cells. (B) In vivo cleavage speciﬁcity proﬁles of mCreI and
mMsoI, determined as described in A by co-transfecting endonuclease coding and target site plasmids into human 293T cells. Relative cleavage
efﬁciencies are plotted as in Figure 3 with the native base pair GFP+ value arbitrarily set to 1.0. All assay values represent the mean of three
replications, with error bars omitted for graphical clarity.
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cleavage reactions that simultaneously assayed all 4bp
possibilities at each base pair position were then displayed
on a single gel for quantitation (Figure 3B).
I-CreI displayed a strong preference for native base
pairs at many target site positions (±1 to ±10) in
cleavage assays (Figure 3B and C, top panels). The
highest cleavage speciﬁcities were observed at target site
positions ±3–4 and ±9–10, and the lowest speciﬁcities at
positions ±1, 2 and 8. Only 5bp substitutions were
cleaved more efﬁciently than the native base pair:
 7A>C,  2G>A, +1G>A, +7G>T and +8T>A.
Two of these substitutions,  7A>C and +7G>T,
increased the overall symmetry of the I-CreI/mCreI
target site.
I-MsoI displayed the highest cleavage speciﬁcity at
target site positions ±3 and ±5, and was least speciﬁc
at target site positions  1 and +7, 8 and 11 (Figure 3B
and C, bottom panels). At positions  1 and+11, I-MsoI
cleaved all 4bp possibilities with equal efﬁciency. A total
of 14bp substitutions at seven target site positions were
cleaved, as well as the corresponding native base pair:
 7A>T,  1T>A/C/G, +2A>C, +7G>A/C/T,
+8T >A/C,+10C>T and+11G>A/C/T. Four of these
substitutions,  1T>C,+2A>C,+7G>T and+10C>T,
increased the overall symmetry of the I-MsoI target site
(Figure 3C, bottom panel).
The global cleavage speciﬁcities of I-CreI and I-MsoI
were calculated from the number of variant target sites
that could be cleaved with  50% of the efﬁciency of the
native site, divided by the number of unique 20bp (I-CreI)
or 22bp (I-MsoI) target sites. These cleavage speciﬁcities
were  1.4 10
 8 for I-CreI and  5.4 10
 5 for I-MsoI.
The corresponding in vitro cleavage speciﬁcity proﬁles for
mCreI and mMsoI were very similar to I-CreI and I-MsoI:
respectively  2.8 10
 8 and  2.4 10
 5 (Supplementary
Figure S2). The higher global binding and cleavage
speciﬁcities of I-CreI versus I-MsoI can be seen easily in
relative binding and cleavage difference plots that
compare the two endonucleases (Supplementary
Figure S3).
In vitro cleavage of target sites with multiple base pair
changes
In order to determine whether single base pair cleavage
data could be used to predict the cleavage sensitivity of
target sites having multiple base pair changes, we analyzed
36 different mCreI target sites containing from 3 to 9bp
differences from the native I-CreI target site (Figure 1).
An explicit example from these analyses is shown in
Figure 5, in which our mCreI cleavage speciﬁcity proﬁles
were used to search for engineerable target sites in the
human SBDS gene to target to catalyze gene repair.
SBDS-inactivating mutations cause Shwachman-
Diamond syndrome (SDS), a rare, heritable bone
marrow failure syndrome characterized by congenital
abnormalities, hematopoietic failure and cancer predis-
position (26). The human SBDS CHS2 mCreI target site
is located in SBDS intron 1, upstream of the location of
>90% of SDS-causing SBDS mutations (27). The CHS2
SBDS site differs at 9bp positions from the native I-CreI
target site (Figure 5A). Our in vitro cleavage data and a
prior systematic protein computation design analysis of
mCreI (25) indicated that four of these base pair differ-
ences should be recognized and cleaved by native I-CreI/
mCreI ( 8,  1, +1 and +2), and an additional 3bp
changes at positions  9,  7 and  5 could be successfully
targeted by previously identiﬁed mCreI protein computa-
tional designs (25). The remaining 2bp differences, at pos-
itions  1 and+7, were predicted to reduce cleavage.
Cleavage analysis of CHS2 site variants containing dif-
ferent combinations of these base pair changes allowed us
to verify the predictions of cleavage sensitivity for the
combined base pair differences at positions  8,  1, +1
and +2, and that substitutions at  1 and +7 reduced
though did not abolish cleavage. Similar analyses of 35
additional target sites chosen on the basis of cleavage de-
generacy data and engineerability with from 3 to 7bp dif-
ferences from the native I-CreI target site revealed that a
majority (31/35, or 89%) predicted to be cleavage-sensitive
from our single base pair scanning data were
cleavage-sensitive, and that 11 of these sites (31%) were
cleaved with efﬁciencies comparable to the native I-CreI
target site. Many target sites with up to three contiguous
base pair changes, each having relative cleavage activities
of >0.5 versus the native site were cleavage-sensitive as
predicted, whereas target sites having four or ﬁve contigu-
ous substitutions where one or two substitutions had
relative cleavage activities of  0.5 in our single base pair
scan data were largely cleavage-resistant (additional
results not shown).
Using single base pair scan data to predict the potential
for evolutionary spread
We also used our single base pair cleavage data to gauge
the potential of I-CreI or I-MsoI for lateral transfer to
additional organisms to identify target site variants that
retained 28S rRNA secondary structure motifs required
for function (the extrahelical +6A base and a paired
stem-loop structure; Figure 6A), and were predicted to
be highly cleavage sensitive from our target site scan
results. The I-CreI site predicted to be the most
cleavage-sensitive by these criteria had  7C and +8G
base pair substitutions. Blastn searches using this site
identiﬁed 75 perfect matches in nucleotide sequence data-
bases, of which 55 were in LSU ribosomal RNA genes.
Two I-MsoI sites with predicted higher cleavage sensitiv-
ity, in contrast, did not have perfect matches that could be
identiﬁed by Blast searching (Supplementary Table S1;
additional results not shown).
In vivo cleavage speciﬁcity
In light of growing interest in using HE proteins for
genome engineering and gene therapy, we also determined
the cleavage speciﬁcities of mCreI and mMsoI in human
cells. These experiments used the same target site libraries
constructed for in vitro cleavage speciﬁcity experiments
(Figure 3). Target site cleavage of site plasmids in vivo
was quantiﬁed from the frequency of cleavage-dependent
generation of recombinant, GFP+cells (Figure 4A) (19).
Nucleic Acids Research,2012, Vol.40, No. 6 2593In vivo cleavage speciﬁcity proﬁles for mCreI and mMsoI
closely resembled those determined in vitro (Figures 3C
and 4B). One conspicuous difference was the overall
higher speciﬁcity of mMsoI cleavage in vivo at right half
site positions +7 to +11. In contrast, mCreI in vitro and
in vivo cleavage speciﬁcity proﬁles closely resembled one
another (Figures 3C and 4B).
DISCUSSION
Relationship of in vitro binding and cleavage speciﬁcities
We observed a strong correlation between binding and
cleavage at many I-CreI and I-MsoI target site positions.
Most substitutions that reduced binding also comparably
reduced cleavage efﬁciency (Figures 2 and 3). Of greater
interest were base pair substitutions that disproportion-
ately affected binding or cleavage: these substitutions
may provide insight into dynamic aspects of binding and
cleavage complex formation. Four I-CreI site
substitutions substantially reduced binding, but retained
>50% of the cleavage activity of the native target site
( 8A>Co rG , 5G>T and  2G>A). One substitu-
tion, +2A>T, displayed native binding afﬁnity but no
detectable cleavage activity. I-MsoI had 15bp substitu-
tions that disproportionately reduced binding versus
cleavage. One I-MsoI substitution, +9T>C, reduced
cleavage by  40%, while enhancing binding to >100%
(Figures 2 and 3). These ‘uncoupling’ base pair substitu-
tions are easy to identify in difference plots that compare
binding and cleavage activity at each target site base pair
position (Supplementary Figure S4).
Base pair substitutions that selectively affect binding
but not cleavage may allow transition state complexes to
be formed that include new stabilizing interactions, or that
do not depend on stabilizing interactions in the ground
state. Conversely, base pair substitutions that selectively
affect cleavage but not binding might create interactions
that stabilized the ground state, or that hindered conform-
ational changes required to form a transition state
Figure 5. In vitro cleavage speciﬁcity proﬁling guides the generation of target site-speciﬁc LHE variants. (A) The workﬂow for engineering mCreI
towards novel target sites, using the human Shwachman-Diamond syndrome gene SBDS CHS2 site as an example. The ﬁrst step is to predict the
cleavage sensitivity of target sites containing multiple base pair changes from single base pair cleavage sensitivity proﬁling data (see, e.g. Figure 2).
These predictions can be experimentally veriﬁed in a second step, and then combined with LHE protein designs to generate a target site-speciﬁc LHE
variant. The activity and speciﬁcity of this novel target site-speciﬁc variant can then be further improved by a combination of selection or screening.
(B) Schematic overview of in vitro competitive cleavage assay. Both native and novel target sites are cloned into a plasmid that is linearized prior to
LHE cleavage. Cleaved products are visualized on an agarose gel to determine the relative cleavage efﬁciency of the native and test sites from relative
band intensities. (C) Agarose gels displaying in vitro cleavage efﬁciency of mCreI on three CHS2 sites that contain different combinations of base pair
changes.
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models by determining the predicted binding energies or
structures of speciﬁc ‘uncoupling’ substitutions captured
in both pre-cleavage and cleavage complexes.
An important determinant of the higher overall speciﬁ-
city of I-CreI is the larger number of direct and
water-mediated contacts made with target site DNA: I-
CreI makes an average of 2.4 contacts (direct or water-
mediated) with each target site position, whereas I-MsoI
makes an average of only 1.7contacts/bp (18). The most
speciﬁc target site positions in both I-CreI and I-MsoI, e.g.
the ±3–5 target site positions (Figures 2 and 3), share
many conserved DNA-protein contacts that may be
required in both proteins to correctly position target site
DNA to promote cleavage (Figure 1C) (16,18). Additional
DNA-protein contacts at positions more distant from the
active sites, e.g. positions ±6–11, help ensure high site
binding afﬁnity and sequence-speciﬁc discrimination.
Target site symmetry also plays an important role in
determining overall site speciﬁcity and, as we discuss
below, is likely to be an important constraint on both
lateral transfer and HE evolution. The importance of
site symmetry is most clearly revealed by base pair substi-
tutions that create a higher degree of I-CreI or I-MsoI
target site symmetry: these substitutions almost invariable
lead to enhanced target site binding and/or cleavage [see,
e.g. (24)].
Site speciﬁcity proﬁling enables HE-mediated genome
engineering applications
HE site speciﬁcity proﬁles provide useful information
to guide the generation of HE variants for genome engin-
eering (6,28–31). Position-speciﬁc search or scoring
matrices (PSSMs) can be constructed from proﬁling
data such as those presented in Figure 2, and used
to identify gene-speciﬁc or genomic target sites that
have a high likelihood of being bound or cleaved by
speciﬁc HEs. The functional consequences of base pair
differences including SNP variants in ‘near match’ sites
can be predicted from proﬁling data, as shown in
Figure 5. The most important target site positions on
which to focus speciﬁcity engineering efforts can be
identiﬁed early, as can genomic target sites where there
are few or no DNA contacts to modify to achieve higher
or altered speciﬁcity (e.g. in the central four target site
positions  2 to+2). Target sites likely to be confounded
by low speciﬁcity or the potential for substantial off-target
cleavage activity can also be identiﬁed and avoided
where there are better alternatives. These results provide
a good example of how single base pair proﬁling data can
be used to determine engineering feasibility, and focus
protein engineering on speciﬁc base pair positions where
protein engineering is required to achieve new site
speciﬁty.
I-CreI and I-MsoI site speciﬁcity versus host target gene
structure
Many HE ORFs are found as open reading frames in large
or small subunit ribosomal RNA genes (the LSU/23/25/
28S and SSU/16S/18S rRNA genes) (16,32). The native
I-CreI/I-MsoI LSU target site resides in a highly
conserved segment of the chloroplast LSU genes of
Chlamydomonas and Monomastix (LSU n.2593, where nu-
cleotide numbering is keyed to the reference Escherichia
coli LSU 23S ribosomal RNA gene sequence) (33). The
corresponding portion of LSU rRNA is located in the
central loop of domain V that includes the peptidyl trans-
ferase center (Figure 6A) (34–36). Nucleotides ﬂanking
the LSU n.2593 insertion site display 2-fold symmetry,
and form a stem-loop structure in rRNA secondary
Figure 6. Location of I-CreI and I-MsoI target sites in host ribosomal RNA genes. (A) The secondary structure of domain V in E. coli 23S rRNA
gene, in which the n.2593 target site region recognized by I-CreI and I-MsoI is shown in red and the intron insertion site indicated by an arrow. The
I-CreI and I-MsoI target sites are aligned below the stem-loop to indicate intron insertion sites (down arrow), strand cleavage sites (ﬁlled arrow
heads) and the location of the extrahelical base at the +6 position that plays a role in peptide release (dot) (38). (B) Aligned sequences of the
corresponding n.2593 target site region from LSU rRNA genes from chloroplast or mitochondrial 23S ribosomal RNA genes of green algae, with the
E. coli 23S ribosomal RNA gene shown at bottom (33). Target sites are surrounded by a red box, with the central four positions ( 2 to+2) shaded
in magenta. Positions conserved across all target sites are underlined with an asterisk.
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by base pairs at nucleotide positions n.2588–2594 (corres-
ponding to Cre/Mso target site positions  9t o 3) and
n.2599–2606 [corresponding to target site positions+3 to
+10; Figures 1 and 6; (37)]. The four nucleotides between
the two-half sites, n.2595–2599, form an unpaired loop in
rRNA that corresponds to the central four nucleotides in
the Cre/Mso target site (positions  2 to +2, Figures 1
and 6A). The A residue at position n.2602, corresponding
to position +6 within the Cre/Mso target site, is
extrahelical in RNA secondary structure models and
has been shown to be essential for ribosomal peptide
release (38).
The n.2588–2606 stem-loop region of LSU rDNA thus
provides a well-deﬁned and highly conserved target for the
lateral transfer of HE-encoding mobile introns. The
binding and cleavage speciﬁcity proﬁles of I-CreI and
I-MsoI reﬂect and exploit these LSU target site con-
straints. LSU bases that form the stem-loop structure in
LSU rRNA correspond to Cre/Mso target site positions
 9t o 3, +3 to +5 and +7 to +10 (Figure 6A), where
I-CreI and I-MsoI display high binding and cleavage spe-
ciﬁcity (Figures 2 and 3). The central 4bp positions ( 2t o
+2) in both target sites, in contrast, are located in a loop
with few or no apparent sequence constraints in rRNA
secondary structure models, and these positions con-
tribute little target site binding or cleavage speciﬁcity
(Figures 2 and 3).
Implications for HE evolution
The near-perfect 2-fold symmetry of the n.2593 LSU
target site is dictated by rRNA functional constraints.
These constraints, in turn, may strongly inﬂuence HE
protein evolution at several levels. One potential advan-
tage of using a highly conserved, largely symmetric target
site for homing is that symmetric sites can be effectively
targeted by small, homodimeric HE proteins encoded by a
single, short open reading frame. This permits homing to
be mediated by the lateral transfer of a small open reading
frame and accompanying intron or intein that is easily and
reliably transferred. Small mobile intron/intein open
reading frames also present a small target for potentially
inactivating mutations.
Duplication or duplication and fusion of an open
reading frame encoding a homodimeric LHE subunit
opens up another evolutionary opportunity: the ability
to target asymmetric, degenerate or non-palindromic
target sites. This strategy can be glimpsed in the structure
of I-MsoI, a symmetric homodimeric LHE which uses
asymmetric contacts to recognize a target site with a
high degree of target site symmetry (18). Another particu-
larly instructive example is I-CeuI, an asymmetric,
homodimeric LHE from Chlamydomonas eugametos that
uses unique structural elaborations on the core LHE fold
to cleave the highly asymmetric n.1923 LSU target site in
C. eugamotes chloroplast DNA. Of note, I-CeuI retains
cleavage activity on symmetric-left or symmetric-right
target sites (39). The ability to cleave related symmetric
and asymmetric target sites could broaden the range of
potential LHE hosts to include organisms with related
asymmetric, as well as symmetric, target sites.
The substantially different structural solutions used by
I-CreI, I-MsoI and I-CeuI to target LSU sites with differ-
ing degrees of asymmetry suggest two different evolution-
ary strategies that may ensure the evolutionary persistence
of HE proteins and their encoding selﬁsh DNA elements.
I-CreI, with a rich set of DNA-protein contacts, can dis-
criminate between closely related target sites (17,18,39).
A potential advantage of this higher site speciﬁcity is the
ability to evolve higher cleavage activity to aid lateral
transfer, without substantially increasing cleavage-
dependent host toxicity (19). I-MsoI and I-CeuI, in
contrast, may be able to spread to a wider range of new
hosts by virtue of less stringent target site sequence
requirements. The potentially deleterious consequences
of lower site speciﬁcity may be offset by lower cleavage
activity, as is the case for I-MsoI. Either of these strategies
for coupling site recognition speciﬁcity and cleavage
activity could represent a viable—or preferred—strategy
for lateral transfer and evolutionary persistence in host
populations with differing degrees of target site sequence
divergence.
Host accommodation following lateral transfer repre-
sents another important determinant of HE evolution.
Several strategies for host accommodation have been
identiﬁed among HEs. These include use of an
HE-encoded maturase function to improve the expression
of host genes; host genetic code adoption and the use of
host codon preferences to improve HE expression; and
modulation of HE protein expression to ensure adequate
expression of both host gene and HE open reading
frame-encoded proteins (6,40,41). It should be possible
to experimentally determine the contribution of these de-
terminants of HE lateral transfer using the systems that
have been developed to study homing and LAGLIDADG
HEs in prokaryotes (22,42,43), single cell eukaryotes
(44,45), and most recently metazoans (46,47).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures S1–S4 and Supplementary Table S1.
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